Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.
Bill Chin, M.D.

Bill Chin, M.D. Dr. Bill Chin is the chief medical officer of PhRMA and leads the Scientific & Regulatory Advocacy department as executive vice president. A physician, an endocrinologist and an academic at heart, Dr. Chin envisions establishing PhRMA as the premiere convener in advancing drug discovery and development, regulatory sciences and collaborative partnerships.

Recent Posts

PhRMA Salutes Outgoing FDA Commissioner’s Leadership, Looks Forward to Continued Collaboration

By Bill Chin, M.D.  |    February 10, 2015
Last week, Food and Drug Administration (FDA) Commissioner Margaret Hamburg announced that she will step down from her post at the end of next month.   Read More

Biopharmaceutical companies reaffirm commitment to patients in updated Principles on Conduct of Clinical Trials and Communication of Clinical Trial Results

By Bill Chin, M.D.  |    December 10, 2014
Researchers in biopharmaceutical companies strive to discover and develop new medicines and vaccines that will help people to live longer, healthier lives.  They go to work every day knowing that...   Read More

Collaboration Between PhRMA and Scientific American Highlights Biomedical Science

By Bill Chin, M.D.  |    October 20, 2014
Scientific progress is complex, time-consuming and expensive. Researchers continue to broaden our collective understanding of disease with the hope that new findings will lead to advancements that...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates